繁
简
Market+ (iPhone)
Market+ (Android)
Mobile Site
US STOCKS
FUNDS
FX & CRYPTO
SH/SZ-HK
HK STOCKS
 
 
 
 
 
 
Quote Service
Market
Market
Quotes
Quotes
Analysis
Analysis
Commentary
Commentary
Warrants&CBBCs
Warrants&CBBCs
Warrants&CBBCs Overview
Warrants
CBBCs
ETF
ETF
MPF
MPF
Education
Members
Members
About Us
About Us

ETF Overview

TRACKER FUND
ISHARES A50
HSCEI ETF
CSOP A50 ETF
CAM CSI300
Last (HKD)1
Details»
Vol. 
Turn. 
Range
NAV (HKD)
Premium%
1-Month Range
2-Month Range
3-Month Range
52-Week Range
1D
1M
Advanced Chart
ETF Overview
Issuer
Expenses & Facts
Analysis
Calendar Yr Chg
Cumulative Chg
Overview (By Turn.)
Overview (By Asset)
Name/ Symbol
Underlying Asset
Last1
Chg
Chg%
Vol.
Turn.
NAV (Premium%)
Chart
Compare
TRACKER FUND
 Hang Seng Index 21.220
 HKD 		+0.220 +1.048% 566.33M 11.98B 23.260 (-8.770%)
HKD as at 2025/02/25
HSCEI ETF
 Hang Seng China Enterprises 79.860
 HKD 		+1.420 +1.810% 111.85M 8.92B 86.975 (-8.181%)
HKD as at 2025/02/25
CSOP HS TECH
 Hang Seng TECH Index 4.800
 HKD 		+0.060 +1.266% 1.30B 6.21B 5.580 (-13.982%)
HKD as at 2025/02/25
XL2CSOPHSTECH
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Hang Seng TECH Index 4.464
 HKD 		+0.156 +3.621% 673.41M 2.99B 6.590 (-32.261%)
HKD as at 2025/02/25
XI2CSOPHSTECH
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Hang Seng TECH Index 2.126
 HKD 		-0.078 -3.539% 1.15B 2.46B 1.831 (+16.086%)
HKD as at 2025/02/25
FI2 CSOP HSI
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Hang Seng Index 3.048
 HKD 		-0.090 -2.868% 291.63M 901.56M 2.726 (+11.816%)
HKD as at 2025/02/25
FL2 CSOP HSI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Hang Seng Index 3.980
 HKD 		+0.118 +3.055% 191.39M 749.50M 5.000 (-20.395%)
HKD as at 2025/02/25
ISHARESHSTECH
 Hang Seng TECH Index 10.250
 HKD 		+0.140 +1.385% 40.42M 414.72M 12.133 (-15.518%)
HKD as at 2025/02/24
HSTECH ETF
 Hang Seng TECH Index 4.880
 HKD 		+0.100 +2.092% 58.65M 285.22M 5.659 (-13.758%)
HKD as at 2025/02/25
SPDR GOLD TRT
 London Gold Fixing Price 2,297.000
 HKD 		+64.000 +2.866% 75.65K 173.82M N/A
FI2CSOPNASDAQ
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 NASDAQ-100 Index 6.060
 HKD 		+0.175 +2.974% 26.59M 162.54M 4.925 (+23.038%)
HKD as at 2025/02/24
ISHARES A50
 FTSE China A50 13.070
 HKD 		+0.060 +0.461% 7.55M 98.84M 13.749 (-4.939%)
HKD as at 2025/02/24
CAM CSI300
 CSI 300 40.920
 HKD 		+0.360 +0.888% 1.84M 75.39M 43.473 (-5.873%)
HKD as at 2025/02/25
FL2 CSOP HSCEI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Hang Seng China Enterprises 2.642
 HKD 		+0.112 +4.427% 26.91M 69.77M 3.260 (-18.945%)
HKD as at 2025/02/25
FL2CSOPGOLD
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Solactive Gold 1-Day Rolling Futures Index 16.160
 HKD 		+0.960 +6.316% 3.24M 52.34M 13.980 (+15.597%)
HKD as at 2025/02/24
CSOP A50 ETF
 FTSE China A50 12.310
 HKD 		+0.310 +2.583% 2.70M 33.01M 12.681 (-2.928%)
HKD as at 2025/02/25
FL2CSOPNASDAQ
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 NASDAQ-100 Index 18.390
 HKD 		-0.900 -4.666% 1.65M 30.03M 25.595 (-28.150%)
HKD as at 2025/02/24
CAM HSI ESG
 HSI ESG Enhanced Index (net total return index) 42.940
 HKD 		+0.440 +1.035% 632.28K 27.14M 47.751 (-10.076%)
HKD as at 2025/02/25
TRACKER FUND-R
 Hang Seng Index 20.080
 CNY 		+0.230 +1.159% 1.18M 23.71M 21.745 (-7.657%)
CNY as at 2025/02/25
A GX HSCEICC
 Hang Seng China Enterprises 9.900
 HKD 		+0.185 +1.904% 2.33M 22.91M 10.808 (-8.404%)
HKD as at 2025/02/24
VALUEGOLD ETF
 London Gold Fixing Price 75.520
 HKD 		+2.420 +3.311% 257.48K 19.44M 69.203 (+9.128%)
HKD as at 2025/02/25
FI CSOP HSI
-1x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Hang Seng Index 4.382
 HKD 		-0.068 -1.528% 4.05M 17.93M 4.098 (+6.920%)
HKD as at 2025/02/25
CSOP UST20
 FTSE US Treasury 20+ Years Index 67.620
 HKD 		-1.660 -2.396% 258.40K 17.48M 70.043 (-3.459%)
HKD as at 2025/02/24
FI2CAMNDQ100
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 NASDAQ-100 Index 0.920
 HKD 		+0.024 +2.679% 18.64M 17.32M 0.748 (+23.060%)
HKD as at 2025/02/24
GX HS HIGH DIV
 Hang Seng High Dividend Yield 23.540
 HKD 		+0.140 +0.598% 644.38K 15.10M 24.714 (-4.751%)
HKD as at 2025/02/24
FI2 CSOP NIKKEI
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Nikkei Stock Average Index 83.080
 HKD 		+5.840 +7.561% 164.95K 13.62M 67.238 (+23.562%)
HKD as at 2025/02/25
CSOP HSI ETF
 Hang Seng Index 21.380
 HKD 		+0.320 +1.519% 613.05K 12.97M 23.346 (-8.420%)
HKD as at 2025/02/25
CAM HSBIOTECH
 Hang Seng Hong Kong-Listed Biotech Index 10.330
 HKD 		+0.410 +4.133% 1.21M 12.37M 10.297 (+0.319%)
HKD as at 2025/02/25
CAM HS TECH
 Hang Seng TECH Index 6.220
 HKD 		+0.110 +1.800% 1.57M 9.72M 7.219 (-13.841%)
HKD as at 2025/02/25
CSOP A50 ETF-R
 FTSE China A50 11.600
 CNY 		+0.130 +1.133% 740.86K 8.60M 11.844 (-2.062%)
CNY as at 2025/02/25
(1) All quotes for Hong Kong Stocks are at least 15 minutes delayed. Last Updated: 2025/04/11 16:08
 
SITEMAP
AASTOCKS.com
 
 
Members
 
About Us
Market
Quotes
 
Analysis
News & Research
 
Commentary
 
Warrants&CBBCs
 
Warrants
 
CBBCs
 
US Stocks
Forex
 
Fund
 
MPF
Email: support@aastocks.com
AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司) All rights reserved.
Disclaimer
AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司), HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

The above is strictly for information purposes only and should not be considered an offer, or solicitation, to deal in any of the mentioned funds. Investment involves risk, emerging markets may have greater risk than developed markets. Subscriptions may only be made on the basis of the relevant offering documents, most recent annual financial statement and semi-annual financial statements if published thereafter. The value of investments and the income received from them (if any) may be volatile and could change substantially within a short period of time. Past performance is not a guide to future performance. The investment returns are denominated in the base currency of the fund. US dollar / HK dollar based investors are therefore exposed to fluctuations in the US dollar / HK dollar / base currency exchange rate.

BEFORE MAKING AN INVESTMENT, YOU SHOULD REFER TO THE RELEVANT OFFERING DOCUMENTS AND IN PARTICULAR TO THE INVESTMENT POLICIES AND THE RISK FACTORS. YOU SHOULD ENSURE THAT YOU FULLY UNDERSTAND THE RISKS ASSOCIATED WITH THE FUND AND SHOULD ALSO CONSIDER YOUR OWN INVESTMENT OBJECTIVE AND RISK TOLERANCE LEVEL. YOU ARE REMINDED THAT YOU ARE RESPONSIBLE FOR YOUR INVESTMENT DECISION AND SHOULD NOT INVEST UNLESS THE INTERMEDIARY WHO OFFERS OR SELLS THE FUND TO YOU HAS ADVISED THAT THE FUND IS SUITABLE FOR YOU AND HAS EXPLAINED WHY, INCLUDING HOW BUYING THE FUND WOULD BE CONSISTENT WITH YOUR INVESTMENT OBJECTIVE. IF IN DOUBT, PLEASE SEEK INDEPENDENT FINANCIAL AND PROFESSIONAL ADVICE.

The information and products contained within this website are restricted to investors within Hong Kong. There are important legal and regulatory restrictions which apply to this website. These are laid out in the Disclaimer section which you are advised to read before proceeding. By proceeding, you are representing that you have understood and accepted the restrictions set out in the Disclaimer section.

Third party websites provided by hyperlinks on this website are completely beyond the control of AASTOCKS. Accordingly, AASTOCKS accepts no responsibility for the accuracy, completeness and legality of the contents of such third party website, or for any offers, services and products contained therein.

Remarks: All HK and China Indices are real time. World indices are at least 30 – 60 minutes delayed.
 
 
 
ETF Comparison
1
2
Compare